Results 201 to 210 of about 229,703 (354)

Conversion Surgery After Administration of a TRK Inhibitor for Unresectable Parotid Gland Secretory Carcinoma

Head &Neck, EarlyView.
ABSTRACT Background The NTRK fusion gene is detected in most salivary gland secretory carcinomas. While tropomyosin receptor kinase (TRK) inhibitors are used for various solid tumors with the fusion gene, there are no reports regarding TRK inhibitor use for unresectable parotid gland carcinomas that subsequently shrink and become resectable.
Arisa Nagano, Takuma Matoba, Daisuke Kawakita, Kiyoshi Minohara, Sho Iwaki, Hiroshi Tsuge, Koji Tsukamoto, Sekai Kikuchi, Satsuki Nakano, Takayuki Murase, Yuichiro Tada, Shinichi Iwasaki   +11 more
wiley   +1 more source

Deep learning-based quantification of eosinophils and lymphocytes shows complementary prognostic effects in colorectal cancer patients. [PDF]

NPJ Precis Oncol
Baumann E, Lechner S, Krebs P, Kirsch R, Berger MD, Lugli A, Nagtegaal ID, Perren A, Zlobec I.   +8 more
europepmc   +1 more source

Eosinophils versus Neutrophils in Host Defense [PDF]

, 1979
David Bass, Pamela Szejda
openalex   +1 more source

PW-BALFC, a clinical dataset for detection and instance segmentation of bronchoalveolar lavage fluid cell. [PDF]

Sci Data
Shi X, Huang Q, Xu T, Mei H, Quan T, Wang X, Shi Y, Hu Y, Duan Z, Xie F, Li S, Xie L, Wang K.   +12 more
europepmc   +1 more source

Comparison of intracellular bactericidal activities of human neutrophils and eosinophils [PDF]

, 1978
LR DeChatelet, RA Migler, PS Shirley, Muss Hb, P Szejda, DA Bass   +5 more
openalex   +1 more source

Blood‐based biomarkers in soft tissue sarcoma: Implications for immune checkpoint inhibitor therapy

International Journal of Cancer, EarlyView.
Abstract Soft tissue sarcoma (STS) is a rare and heterogeneous cancer, comprising approximately 1% of all adult cancers and 7%–15% of all childhood cancers. In the advanced stages, chemotherapy remains the standard‐of‐care, but efficacy is limited, with a response rate of 15%–30%, and responses are often short‐lived, with median progression‐free ...
Brie‐Anne Mannah, John J. Park, Su Yin Lim   +2 more
wiley   +1 more source

Commentary: Tissue eosinophil level as a predictor of control, severity, and recurrence of Chronic Rhinosinusitis with Nasal Polyps. [PDF]

Front Allergy
Gelardi M.
europepmc   +1 more source

Reactivity of Rabbit Antiserum to Guinea Pig Eosinophils [PDF]

, 1975
Gerald J. Gleich, David A. Loegering, Gail M. Olson   +2 more
openalex   +1 more source

Eosinophils on trial [PDF]

Clinical & Experimental Allergy, 2018
Timothy J. Williams, James E. Pease, James E. Pease   +2 more
openaire   +5 more sources

Tumor desialylation surpasses anti‐PD‐L1 checkpoint therapy in restoring anti‐tumor immunity in a murine model for colorectal cancer

International Journal of Cancer, EarlyView.
What's New? Our research highlights how tumor sialylation affects tumor growth and reshapes the immune tumor microenvironment in colorectal cancer. We demonstrate for the first time that complete removal of sialic acids from colorectal tumor cells elicits a robust anti‐tumor immune response, but does not enhance anti‐PD‐L1 blockade efficacy.
Irene van der Haar Àvila, Tao Zhang, Victor Lorrain, Eelco Keuning, Laraib Amir Ali, Cora Chadick, Sara García‐García, Louis Boon, Noortje de Haan, Juan J. García‐Vallejo, Yvette van Kooyk, Sandra J. van Vliet   +11 more
wiley   +1 more source